Cargando…
SARS-CoV-2 Infection Triggers Phosphorylation: Potential Target for Anti-COVID-19 Therapeutics
The SARS-CoV-2 infection triggers host kinases and is responsible for heavy phosphorylation in the host and also in the virus. Notably, phosphorylations in virus were achieved using the host enzyme for its better survival and further mutations. We have attempted to study and understand the changes t...
Autores principales: | Chatterjee, Bhaswati, Thakur, Suman S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891488/ https://www.ncbi.nlm.nih.gov/pubmed/35251015 http://dx.doi.org/10.3389/fimmu.2022.829474 |
Ejemplares similares
-
Remdesivir and Its Combination With Repurposed Drugs as COVID-19 Therapeutics
por: Chatterjee, Bhaswati, et al.
Publicado: (2022) -
ACE2 as a potential therapeutic target for pandemic COVID-19
por: Chatterjee, Bhaswati, et al.
Publicado: (2020) -
Puerarin: A Potential Therapeutic for SARS-CoV-2 and Hantavirus Co-Infection
por: Liang, Weizheng, et al.
Publicado: (2022) -
Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19
por: Zhou, Hong, et al.
Publicado: (2022) -
Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan
por: Chao, Chiao-Hsuan, et al.
Publicado: (2022)